sodium iodide i-123 · Cardinal Health 418 · NDA 017630, 018671
Sodium Iodide I 123
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 6
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 017630 · 001 · discontinued | capsule, oral | 100uCi | open |
| 017630 · 002 · discontinued | solution, oral | 2mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | open |
| 017630 · 003 · discontinued | capsule, oral | 200uCi | open |
| 018671 · 001 · RLD | capsule, oral | 100uCi | open |
| 018671 · 002 · RLD | capsule, oral | 200uCi | open |
| 018671 · 003 · discontinued | capsule, oral | 400uCi | open |